Literature DB >> 15235132

Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese.

Michael A Heneghan1, Philip J Johnson, Michael Clare, Stephen Ho, Phillip M Harrison, Peter T Donaldson.   

Abstract

BACKGROUND: The genetic basis of susceptibility to hepatocellular carcinoma (HCC) is poorly understood. Genomic DNA was available from 98 patients with HCC, 77 familial controls, 97 controls from Hong Kong and 96 Northern European controls (NECs).
METHODS: Polymorphisms of interleukin (IL)-1beta; IL-1 receptor antagonist (IL-1RN); IL-10 promoter (positions -1082, -819, and -592); and tumor necrosis factor (TNF)-alpha promoter (TNF-a -238 and -308) were investigated.
RESULTS: There was marked restriction in the distribution of the IL-1beta and IL-1RN genotypes among Chinese subjects with a predominance of the IL-1beta*1,1 and IL-1RN*1,1 (for unrelated controls compared with NECs only for IL-1beta: chi2 = 15.32, Pc = 0.000091 and for IL-1RN: chi2 = 16.08, Pc = 0.000061). For IL-10, the distribution of alleles was reversed in Chinese vs NECs. The TNFA*2 allele (TNFA -308 A), which is associated with high TNF-alpha production both in vivo and in vitro, was found in <10% of Chinese but was present in 33% of NECs (chi2 = 21.52, Pc <0.0000035).
CONCLUSION: Though this study failed to highlight specific associations between any of the polymorphisms tested and the HCC in Hong Kong Chinese, the differences in the distribution of tested alleles may, in part, account for the increased susceptibility of the Chinese population to develop HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15235132     DOI: 10.1385/IJGC:34:1:19

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  28 in total

1.  p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.

Authors:  R M Lunn; Y J Zhang; L Y Wang; C J Chen; P H Lee; C S Lee; W Y Tsai; R M Santella
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

2.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

Authors:  A G Wilson; F S di Giovine; A I Blakemore; G W Duff
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

Review 3.  The epidemiology of hepatocellular carcinoma.

Authors:  P J Johnson
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-09       Impact factor: 2.566

4.  Geographic variation of p53 mutational profile in nonmalignant human liver.

Authors:  F Aguilar; C C Harris; T Sun; M Hollstein; P Cerutti
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

5.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.

Authors:  J K Tarlow; A I Blakemore; A Lennard; R Solari; H N Hughes; A Steinkasserer; G W Duff
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

6.  Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.

Authors:  C J Edwards-Smith; J R Jonsson; D M Purdie; A Bansal; C Shorthouse; E E Powell
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

9.  Cytokine inhibition of the hepatitis B virus core promoter.

Authors:  R Romero; J E Lavine
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

10.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  21 in total

1.  The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis.

Authors:  Yu Yang; Chao Luo; R Feng; Sheng Bi
Journal:  J Cancer Res Clin Oncol       Date:  2010-11-24       Impact factor: 4.553

Review 2.  TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis.

Authors:  Xu-Feng Guo; Jun Wang; Shi-Jie Yu; Jia Song; Meng-Yao Ji; Zhuo Cao; Ji-Xiang Zhang; Jing Wang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.

Authors:  Yong-Gang Wei; Fei Liu; Bo Li; Xi Chen; Yu Ma; Lv-Nan Yan; Tian-Fu Wen; Ming-Qing Xu; Wen-Tao Wang; Jia-Yin Yang
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

Review 4.  Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.

Authors:  Yonggang Wei; Fei Liu; Bo Li; Xi Chen; Yu Ma; Lvnan Yan; Tianfu Wen; Mingqing Xu; Wentao Wang; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2011-02-19       Impact factor: 3.199

5.  Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Yonggang Wei; Limei Luo; Xi Chen; Lvnan Yan; Bo Li
Journal:  Tumour Biol       Date:  2012-10-12

6.  Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA.

Authors:  Simona Ognjanovic; Jian-Min Yuan; Ann K Chaptman; Yunhua Fan; Mimi C Yu
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

7.  Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk.

Authors:  Xin Tian; Ping Ma; Chengguang Sui; Yan Li; Liye Fu; Tao Jiang; Yang Wang; Youhong Jiang
Journal:  Tumour Biol       Date:  2013-08-13

8.  The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.

Authors:  Qi Ding; Ying Shi; Bo Fan; Zhijiang Fan; Li Ding; Feng Li; Wenjian Tu; Xiaohua Jin; Jing Wang
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis.

Authors:  Ping Zhou; Guo-Qiang Lv; Jian-Zhong Wang; Cheng-Wan Li; Liang-Feng Du; Chun Zhang; Jian-Ping Li
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

10.  IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis.

Authors:  Ying Zhang; Changming Liu; Huiping Peng; Jianzhi Zhang; Quanlin Feng
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.